Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maroun

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|April 1, 1988
Clinical response to trimetrexate as sole therapy for nonsmall cell lung cancerJ Maroun
Annales De Chirurgie|January 1, 1992
[Diverticulosis and Crohn's disease of the sigmoid]A Naouri, J Maroun, E Tissot
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 15, 2011
Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guidelineD J Jonker, K Spithoff, J Maroun, et al.
Current Oncology (Toronto, Ont.)|July 14, 2012
Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancerD Jonker, R B Rumble, J Maroun, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 31, 1999
Neoadjuvant chemotherapy before surgery for resectable carcinoma of the lower esophagusD Jonker, R Mehran, J Maroun, et al.
The Oncologist|October 5, 2001
Optimizing the use of irinotecan in colorectal cancerD Cunningham, J Maroun, U Vanhoefer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2009
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic reviewS Welch, K Spithoff, R B Rumble, et al.
Cancer Investigation|January 1, 1990
Sequential methotrexate, 5-fluorouracil, and leucovorin in metastatic measurable colorectal cancer. Does it work?B Weinerman, J Maroun, D Stewart, et al.
The Oncologist|October 5, 2001
Answering patients' needs: oral alternatives to intravenous therapyM Borner, W Scheithauer, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Raltitrexed: current clinical status and future directionsE Van Cutsem, D Cunningham, J Maroun, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|April 1, 1988
Clinical response to trimetrexate as sole therapy for nonsmall cell lung cancerJ Maroun
Annales De Chirurgie|January 1, 1992
[Diverticulosis and Crohn's disease of the sigmoid]A Naouri, J Maroun, E Tissot
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 15, 2011
Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guidelineD J Jonker, K Spithoff, J Maroun, et al.
Current Oncology (Toronto, Ont.)|July 14, 2012
Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancerD Jonker, R B Rumble, J Maroun, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 31, 1999
Neoadjuvant chemotherapy before surgery for resectable carcinoma of the lower esophagusD Jonker, R Mehran, J Maroun, et al.
The Oncologist|October 5, 2001
Optimizing the use of irinotecan in colorectal cancerD Cunningham, J Maroun, U Vanhoefer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2009
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic reviewS Welch, K Spithoff, R B Rumble, et al.
Cancer Investigation|January 1, 1990
Sequential methotrexate, 5-fluorouracil, and leucovorin in metastatic measurable colorectal cancer. Does it work?B Weinerman, J Maroun, D Stewart, et al.
The Oncologist|October 5, 2001
Answering patients' needs: oral alternatives to intravenous therapyM Borner, W Scheithauer, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Raltitrexed: current clinical status and future directionsE Van Cutsem, D Cunningham, J Maroun, et al.
Pageof 5